Cronos (TSX:CRON) Stock: $0 or $30?

Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) is a millionaire-maker stock. The only problem is that it’s also a millionaire-destroyer stock. It all depends on timing. In 2016, shares traded at $0.20. At the start of 2019, they touched $30. In just three years, a $5,000 investment became $750,000. Then the cannabis bear market of 2019 occurred. The industry lost billions of dollars…

Read More

Is It Time to Buy a Cannabis Rebound?

It would be really nice to blame the current downward spiral within the cannabis industry on the pandemic, but that simply isn’t the case. Since legalization in October of 2018, the entire industry has gone down almost across the board. Companies that soared from penny stock status to even triple digits within two years have now levelled out. Today, it’s…

Read More

Could CannTrust Holdings (TSX:TRST) Stock Recover in 2020?

A beleaguered CannTrust Holdings’s (TSX:TRST)(NYSE:CTST) stock remains heavily beaten down today, even as the company appears much closer to regaining its licences and has preserved cash flow during the period with suspended operating licences. Shares traded around $1.20 exit 2019, and they had recorded an agonizing low of $0.99 a share recently — a price point too bearish, even after…

Read More

Akerna Corp. (NASDAQ: KERN) Surges 56% After Reporting Fiscal First Quarter 2020 Financial Results

Akerna Corp. (NASDAQ: KERN) is engaged as a cannabis technology company, which aims to help cannabis startups navigate the complexities of compliance and maintaining regulatory good-standing. The company’s system helps track regulated cannabis products from seed-to-store. Akerna has tracked over $16 billion in cannabis sales since its launch. Shares of the cannabis technology company surged 56.30%, through trading on Friday,…

Read More

Captor Capital Resumes Trading on the OTCQX® Best Market

TORONTO, Nov. 11, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”) (CSE: CPTR) is pleased to announce that the Company’s stock has resumed on the OTCQX® Best Market following a full revocation of the cease trade order previously issued against the Company Ontario Securities Commission (the “CTO”). The CTO…

Read More

Why Aurora (TSX:ACB) Stock Is Worse for Trading Than Canopy Growth (TSX:WEED) Stock

For some reason, investors are more interested in Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock than in Canopy Growth (TSX:WEED)(NYSE:CGC) stock. However, I believe the latter is a better stock to invest in. Being in the cannabis industry and losing money, both companies are speculative investments. It doesn’t matter if the businesses experience extraordinary revenue growth when they’re posting net losses. As a…

Read More

Why Aurora Cannabis (TSX:ACB) Is Still Overvalued

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is a stock that has seen better years. After starting the year at $7.09, it has since fallen to $5.82–a 13.6% decline. On Aurora’s bumpy ride, there have been opportunities for short term traders to make money. However, the stock has overall been a losing proposition–particularly since March. When you’ve got a stock that’s falling while growing…

Read More

Why Did OrganiGram Holdings (TSXV:OGI) Rise 9.6% Yesterday?

Shares of Canada-based cannabis company OrganiGram Holdings (TSXV:OGI)(NASDAQ:OGI) rose close to 10% yesterday. The stock closed trading at $6.30 per share. OGI was listed as a public company on August 22, 2019, and closed trading on $6.51 that day. It reached a high of $6.85 on August 28 and a low of $5.5 on September 3. OGI shares were trading…

Read More

Why Curaleaf Holdings (CNSX:CURA) Rose 10% in the Last Week

Shares of leading cannabis company Curaleaf Holdings (CNSX:CURA) have risen 10% in the last week of August 2019. The stock is currently trading at $9.41. Despite the recent rally, Curaleaf shares are still trading 40% below their 52-week high. Stock rose despite missing revenue and earnings estimate Curaleaf is a Canada-based vertically integrated cannabis company in the U.S. Curaleaf announced…

Read More

“Low-Risk” Investors: 2 New Routes to Cannabis Exposure

There are several trains of thought when it comes to cannabis investing at the moment. While the serious capital gains enjoyed by traders in 2018 seem to have been consigned to recent history, investors are now eyeing stocks that could cash in on the coming legalization of edibles and other peripheral marijuana products this fall. Another set of investors are…

Read More